The Hill, May 15, 2018

Pharmacy benefit managers (PBM) — the “middlemen” in drug price negotiations — are under attack, and, for the past 15 years, Mark Merritt has been the point man in charge of defending them.

Facebook icon
LinkedIn icon
Twitter icon